Cash flow Altimmune, Inc.

Equities

ALT

US02155H2004

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-01-20 EST			5-day change	1st Jan Change
4.230 ^USD	-0.24%		+5.49%	+17.17%

01-05	Altimmune, Inc. Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH	CI
01-05	Altimmune Says US FDA Grants Breakthrough Therapy Designation for Pemvidutide in MASH	MT

5188aa8.Ru1Xk9bXElk-hoKLGJGCOeMhm_oTHgfL1pBfJsZKaN8.H6su8aykeCpf09rUVd7MaowUy4pyXX2UiflyRZJnB5M_1BXXlKZoD2bfug

Published financial data: ALTIMMUNE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	8.19M	4.41M	-68K	426K	20K
Total Revenues	8.19M	4.41M	-68K	426K	20K
Cost of Goods Sold, Total	33.51M	73.84M	70.45M	65.8M	82.23M
Gross Profit	-25.32M	-69.43M	-70.52M	-65.37M	-82.21M
Selling General & Admin Expenses, Total	13.21M	15.41M	17.13M	18.14M	20.97M
Other Operating Expenses, Total	13.21M	15.41M	17.13M	18.14M	20.97M
Operating Income	-38.53M	-84.84M	-87.65M	-83.51M	-103M
Interest Expense, Total	-9.42K	-5.66K	-8K	-35K	-9K
Interest And Investment Income	323K	203K	2.87M	7.35M	8.07M
Net Interest Expenses	313K	197K	2.86M	7.32M	8.06M
Other Non Operating Income (Expenses)	24.15K	-374K	-32K	166K	48K
EBT, Excl. Unusual Items	-38.2M	-85.02M	-84.82M	-76.03M	-95.06M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Asset Writedown	-	-11.37M	-	-12.42M	-
In Process R&D Expenses	-	-	-	-	-
Other Unusual Items	-16.27M	-700K	-86K	-	-
EBT, Incl. Unusual Items	-54.46M	-97.09M	-84.91M	-88.45M	-95.06M
Income Tax Expense	-5.42M	-	-197K	-	-
Earnings From Continuing Operations	-49.04M	-97.09M	-84.71M	-88.45M	-95.06M
Net Income to Company	-49.04M	-97.09M	-84.71M	-88.45M	-95.06M
Net Income - (IS)	-49.04M	-97.09M	-84.71M	-88.45M	-95.06M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-49.04M	-97.09M	-84.71M	-88.45M	-95.06M
Net Income to Common Excl. Extra Items	-49.04M	-97.09M	-84.71M	-88.45M	-95.06M
Per Share Items
Net EPS - Basic	-1.91	-2.35	-1.81	-1.66	-1.34
Basic EPS - Continuing Operations	-1.91	-2.35	-1.81	-1.66	-1.34
Basic Weighted Average Shares Outstanding	25.64M	41.28M	46.93M	53.25M	71M
Net EPS - Diluted	-1.91	-2.35	-1.81	-1.66	-1.34
Diluted EPS - Continuing Operations	-1.91	-2.35	-1.81	-1.66	-1.34
Diluted Weighted Average Shares Outstanding	25.64M	41.28M	46.93M	53.25M	71M
Normalized Basic EPS	-0.93	-1.29	-1.13	-0.89	-0.84
Normalized Diluted EPS	-0.93	-1.29	-1.13	-0.89	-0.84
Supplemental Items
EBITDA	-38.24M	-84.29M	-87.61M	-83.03M	-103M
EBITA	-38.49M	-84.82M	-87.65M	-83.51M	-103M
EBIT	-38.53M	-84.84M	-87.65M	-83.51M	-103M
EBITDAR	-37.83M	-83.79M	-87.11M	-82.53M	-102M
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	9.95	-	0.23	-	-
Current Domestic Taxes	-5.42M	-	-197K	-	-
Total Current Taxes	-5.42M	-	-197K	-	-
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-23.87M	-53.14M	-53.02M	-47.52M	-59.41M
Interest on Long-Term Debt	9.42K	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	13.21M	15.41M	17.13M	18.14M	20.97M
Research And Development Expense From Footnotes	49.77M	74.54M	70.54M	65.8M	82.23M
Net Rental Expense, Total	407K	500K	500K	500K	500K
Imputed Operating Lease Interest Expense	17.2K	13.46K	24.07K	156K	30.61K
Imputed Operating Lease Depreciation	390K	487K	476K	344K	469K
Stock-Based Comp., COGS (Total)	358K	1.66M	2.84M	4.76M	6.35M
Stock-Based Comp., G&A Exp. (Total)	2.22M	3.86M	5.27M	5.88M	8.04M
Total Stock-Based Compensation	2.58M	5.52M	8.1M	10.64M	14.39M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	116M	190M	111M	135M	36.93M
Short Term Investments	100M	-	73.78M	62.7M	94.96M
Total Cash And Short Term Investments	216M	190M	185M	198M	132M
Accounts Receivable, Total	4.61M	429K	173K	1.11M	544K
Other Receivables	7.76M	5.41M	2.37M	3.74M	2.57M
Total Receivables	12.37M	5.84M	2.54M	4.85M	3.12M
Prepaid Expenses	1.93M	7.95M	5.36M	6.82M	2.1M
Restricted Cash	34.17K	34.17K	34K	41K	42K
Other Current Assets, Total	-	-	-	100K	100K
Total Current Assets	230M	204M	193M	210M	137M
Gross Property Plant And Equipment	3.56M	4.29M	3.18M	2.99M	4.26M
Accumulated Depreciation	-1.6M	-2.05M	-1.5M	-1.98M	-2.21M
Net Property Plant And Equipment	1.96M	2.25M	1.68M	1.01M	2.05M
Goodwill	-	-	-	-	-
Other Intangibles, Total	12.82M	12.42M	12.42M	-	-
Other Long-Term Assets, Total	73.41K	73.8K	19K	-	-
Total Assets	245M	219M	207M	211M	139M
Liabilities
Accounts Payable, Total	612K	2.03M	4.8M	2.07M	211K
Accrued Expenses, Total	11.03M	9.74M	10.63M	9.58M	9.98M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	357K	411K	452K	496K	279K
Current Income Taxes Payable	-	-	1.17M	-	-
Unearned Revenue Current, Total	19.75K	-	-	-	-
Other Current Liabilities	-	6.09M	-	-	-
Total Current Liabilities	12.02M	18.28M	17.05M	12.14M	10.47M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	1.47M	1.12M	672K	175K	1.4M
Unearned Revenue Non Current	250K	250K	250K	160K	160K
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	5.5M	80.54K	3.66M	4.06M	3.77M
Total Liabilities	19.24M	19.73M	21.64M	16.54M	15.8M
Preferred Stock Convertible	-	-	-	-	-
Preferred Stock - Others	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	3.7K	4.09K	5K	7K	7K
Additional Paid In Capital	417M	497M	568M	665M	690M
Retained Earnings	-186M	-293M	-378M	-466M	-561M
Comprehensive Income and Other	-5.04M	-5.04M	-5.23M	-5M	-4.97M
Total Common Equity	226M	199M	185M	194M	124M
Total Equity	226M	199M	185M	194M	124M
Total Liabilities And Equity	245M	219M	207M	211M	139M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	36.98M	42.92M	49.28M	70.9M	77.01M
ECS Total Common Shares Outstanding	36.97M	40.69M	49.2M	70.68M	72.35M
Book Value / Share	6.11	4.89	3.77	2.75	1.71
Tangible Book Value	213M	187M	173M	194M	124M
Tangible Book Value Per Share	5.76	4.59	3.51	2.75	1.71
Total Debt	1.82M	1.54M	1.12M	671K	1.68M
Net Debt	-214M	-189M	-184M	-197M	-130M
Debt Equivalent Oper. Leases	3.26M	4M	4M	4M	4M
Account Code - Inventory Valuation	3	3	-	3	3
Machinery, Total	1.31M	1.55M	652K	699K	699K
Full Time Employees	43	47	52	59	59

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-49.04M	-97.09M	-84.71M	-88.45M	-95.06M
Depreciation & Amortization - CF	251K	531K	-205K	477K	238K
Amortization of Goodwill and Intangible Assets - (CF)	46.81K	19.92K	-	-	-
Depreciation & Amortization, Total	298K	551K	-205K	477K	238K
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-2.47M	-3.85M
Asset Writedown & Restructuring Costs	-	11.95M	-	12.42M	-
Stock-Based Compensation (CF)	2.58M	5.52M	8.1M	10.64M	14.39M
Other Operating Activities, Total	16.25M	1.08M	120K	-154K	-48K
Change In Accounts Receivable	-3.59M	4.18M	256K	-938K	567K
Change In Accounts Payable	594K	1.42M	2.77M	-2.73M	-1.86M
Change in Unearned Revenues	-	-	-	-	-
Change In Income Taxes	-7.13M	2.35M	3.04M	-1.37M	1.17M
Change In Deferred Taxes	-	-	-	-	-
Change in Other Net Operating Assets	5.62M	-8.21M	8.04M	-3.23M	4.6M
Cash from Operations	-34.44M	-78.24M	-62.59M	-75.81M	-79.85M
Capital Expenditure	-204K	-12.12M	-126K	-47K	-
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-138K	-195K	-	-	-
Investment in Marketable and Equity Securities, Total	-71.75M	99.83M	-73.27M	13.78M	-28.39M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-72.09M	87.52M	-73.4M	13.73M	-28.39M
Short Term Debt Issued, Total	632K	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	632K	-	-	-	-
Short Term Debt Repaid, Total	-632K	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-632K	-	-	-	-
Issuance of Common Stock	213M	65.22M	56.78M	86.93M	10.89M
Repurchase of Common Stock	-	-	-	-539K	-850K
Issuance of Preferred Stock	-	-	-	-	-
Repurchase of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-	-119K	-	-285K	-
Cash from Financing	213M	65.1M	56.78M	86.1M	10.04M
Foreign Exchange Rate Adjustments	-	-	-	-	-
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	107M	74.38M	-79.2M	24.03M	-98.19M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Levered Free Cash Flow	-25.74M	-52.56M	-42.39M	-49.98M	-44.87M
Unlevered Free Cash Flow	-25.73M	-52.56M	-42.38M	-49.96M	-44.86M
Change In Net Working Capital	4.18M	-6.71M	-4.63M	8.83M	-4.99M
Net Debt Issued / Repaid	0	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-16.1	-22.86	-25.73	-25	-36.85
Return on Total Capital	-17.52	-24.76	-28.31	-27.38	-40.31
Return On Equity %	-36.14	-45.69	-44.07	-46.63	-59.86
Return on Common Equity	-36.14	-45.69	-44.07	-46.63	-59.86
Margin Analysis
Gross Profit Margin %	-309.4	-1.57K	104K	-15.35K	-411K
SG&A Margin	161.39	349.48	-25.2K	4.26K	105K
EBITDA Margin %	-467.14	-1.91K	129K	-19.49K	-515K
EBITA Margin %	-470.21	-1.92K	129K	-19.6K	-516K
EBIT Margin %	-470.78	-1.92K	129K	-19.6K	-516K
Income From Continuing Operations Margin %	-599.2	-2.2K	125K	-20.76K	-475K
Net Income Margin %	-599.2	-2.2K	125K	-20.76K	-475K
Net Avail. For Common Margin %	-599.2	-2.2K	125K	-20.76K	-475K
Normalized Net Income Margin	-291.66	-1.2K	77.96K	-11.15K	-297K
Levered Free Cash Flow Margin	-314.44	-1.19K	62.34K	-11.73K	-224K
Unlevered Free Cash Flow Margin	-314.37	-1.19K	62.33K	-11.73K	-224K
Asset Turnover
Asset Turnover	0.05	0.02	-0	0	0
Fixed Assets Turnover	4.35	2.1	-0.03	0.32	0.01
Receivables Turnover (Average Receivables)	2.91	1.75	-0.23	0.66	0.02
Short Term Liquidity
Current Ratio	19.16	11.17	11.31	17.26	13.11
Quick Ratio	18.99	10.73	10.99	16.69	12.9
Operating Cash Flow to Current Liabilities	-2.86	-4.28	-3.67	-6.24	-7.63
Days Sales Outstanding (Average Receivables)	125.91	208.51	-1.62K	550.07	15.14K
Average Days Payable Outstanding	3.44	6.54	17.71	19.07	5.08
Long Term Solvency
Total Debt/Equity	0.81	0.77	0.61	0.35	1.36
Total Debt / Total Capital	0.8	0.76	0.6	0.34	1.34
LT Debt/Equity	0.65	0.56	0.36	0.09	1.14
Long-Term Debt / Total Capital	0.64	0.56	0.36	0.09	1.12
Total Liabilities / Total Assets	7.85	9.01	10.46	7.85	11.34
EBIT / Interest Expense	-4.09K	-15K	-10.96K	-2.39K	-11.46K
EBITDA / Interest Expense	-4.02K	-14.81K	-10.89K	-2.36K	-11.38K
(EBITDA - Capex) / Interest Expense	-4.04K	-16.96K	-10.9K	-2.36K	-11.38K
Total Debt / EBITDA	-0.05	-0.02	-0.01	-0.01	-0.02
Net Debt / EBITDA	5.66	2.25	2.11	2.39	1.27
Total Debt / (EBITDA - Capex)	-0.05	-0.02	-0.01	-0.01	-0.02
Net Debt / (EBITDA - Capex)	5.63	1.97	2.11	2.39	1.27
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	41.09	-46.12	-101.54	-726.47	-95.31
Gross Profit, 1 Yr. Growth %	124.82	174.17	1.57	-7.3	25.75
EBITDA, 1 Yr. Growth %	97.32	121.21	3.94	-4.74	23.97
EBITA, 1 Yr. Growth %	96.19	120.4	3.31	-4.73	23.54
EBIT, 1 Yr. Growth %	94.96	120.18	3.31	-4.73	23.54
Earnings From Cont. Operations, 1 Yr. Growth %	139.01	97.96	-12.75	4.41	7.48
Net Income, 1 Yr. Growth %	139.01	97.96	-12.75	4.41	7.48
Normalized Net Income, 1 Yr. Growth %	102.33	122.59	-0.23	-10.37	25.03
Diluted EPS Before Extra, 1 Yr. Growth %	19.72	22.94	-23.04	-8.23	-19.4
Accounts Receivable, 1 Yr. Growth %	351.46	-90.7	-59.67	542.2	-51.04
Net Property, Plant and Equip., 1 Yr. Growth %	8.78	14.55	-25.33	-39.53	102.37
Total Assets, 1 Yr. Growth %	353.43	-10.71	-5.45	1.79	-33.87
Tangible Book Value, 1 Yr. Growth %	549.79	-12.36	-7.41	12.28	-36.37
Common Equity, 1 Yr. Growth %	396.21	-11.84	-6.95	4.75	-36.37
Cash From Operations, 1 Yr. Growth %	258.64	128.06	-20.01	21.13	5.33
Capital Expenditures, 1 Yr. Growth %	16.52K	5.84K	-98.96	-62.7	-
Levered Free Cash Flow, 1 Yr. Growth %	220.69	105.28	-19.35	19.88	-10.23
Unlevered Free Cash Flow, 1 Yr. Growth %	220.67	105.31	-19.36	19.84	-10.2
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-10.99	-12.81	-90.89	-68.92	-45.77
Gross Profit, 2 Yr. CAGR %	76.51	148.27	66.87	-2.97	7.97
EBITDA, 2 Yr. CAGR %	47.43	108.57	51.63	-0.75	8.67
EBITA, 2 Yr. CAGR %	47	107.94	50.91	-0.79	8.49
EBIT, 2 Yr. CAGR %	46.75	107.19	50.82	-0.79	8.49
Earnings From Cont. Operations, 2 Yr. CAGR %	11.9	117.52	31.43	-4.55	5.93
Net Income, 2 Yr. CAGR %	11.9	117.52	31.43	-4.55	5.93
Normalized Net Income, 2 Yr. CAGR %	36.9	112.22	49.02	-5.44	5.86
Diluted EPS Before Extra, 2 Yr. CAGR %	-64.47	21.32	-2.73	-15.96	-14
Accounts Receivable, 2 Yr. CAGR %	15.4	-35.2	-80.63	60.93	77.33
Net Property, Plant and Equip., 2 Yr. CAGR %	20.84	11.62	-7.52	-32.81	10.62
Total Assets, 2 Yr. CAGR %	111.59	101.21	-8.12	-1.9	-17.95
Tangible Book Value, 2 Yr. CAGR %	148.65	138.63	-9.92	1.96	-15.48
Common Equity, 2 Yr. CAGR %	116.22	109.16	-9.43	-1.27	-18.36
Cash From Operations, 2 Yr. CAGR %	91.52	185.45	35.07	-1.56	12.95
Capital Expenditures, 2 Yr. CAGR %	-54.27	9.84K	-21.4	-93.77	-
Levered Free Cash Flow, 2 Yr. CAGR %	325.75	155.92	28.66	-2.49	3.74
Unlevered Free Cash Flow, 2 Yr. CAGR %	326.46	155.94	28.67	-2.51	3.74
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-8.65	-24.7	-77.28	-62.66	-83.45
Gross Profit, 3 Yr. CAGR %	48.92	104.42	84.31	37.18	5.79
EBITDA, 3 Yr. CAGR %	33.73	68.59	65.36	29.65	6.89
EBITA, 3 Yr. CAGR %	33.79	68.25	64.71	29.46	6.74
EBIT, 3 Yr. CAGR %	33.69	68	64.3	29.41	6.74
Earnings From Cont. Operations, 3 Yr. CAGR %	1.85	35.33	60.42	21.72	-0.7
Net Income, 3 Yr. CAGR %	1.85	35.33	60.42	21.72	-0.7
Normalized Net Income, 3 Yr. CAGR %	33.25	60.98	65.01	25.79	3.79
Diluted EPS Before Extra, 3 Yr. CAGR %	-74.76	-46.27	4.24	-4.6	-17.12
Accounts Receivable, 3 Yr. CAGR %	6.6	-50.15	-44.67	-37.77	8.24
Net Property, Plant and Equip., 3 Yr. CAGR %	48.14	18.7	-2.38	-19.73	-2.97
Total Assets, 3 Yr. CAGR %	57.26	58.71	56.43	-4.93	-13.98
Tangible Book Value, 3 Yr. CAGR %	581.35	75.64	74.05	-3.06	-12.87
Common Equity, 3 Yr. CAGR %	78.98	60.34	59.67	-4.93	-14.72
Cash From Operations, 3 Yr. CAGR %	19.43	102.74	86.8	30.25	0.68
Capital Expenditures, 3 Yr. CAGR %	21.96	131.6	368.28	-38.69	-
Levered Free Cash Flow, 3 Yr. CAGR %	3.86	233.28	74.15	24.97	-5.14
Unlevered Free Cash Flow, 3 Yr. CAGR %	3.86	233.67	74.16	24.96	-5.14
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.95	6.39	-63.67	-47.15	-67.83
Gross Profit, 5 Yr. CAGR %	128.2	77.1	55.86	51.73	48.81
EBITDA, 5 Yr. CAGR %	49.05	52.31	40.53	36.39	39.65
EBITA, 5 Yr. CAGR %	48.95	52.31	40.39	36.21	39.37
EBIT, 5 Yr. CAGR %	48.76	52.11	40.3	36.08	39.17
Earnings From Cont. Operations, 5 Yr. CAGR %	49.13	54.34	12.78	17.69	35.88
Net Income, 5 Yr. CAGR %	49.13	54.34	12.78	17.69	35.88
Normalized Net Income, 5 Yr. CAGR %	48.16	52.18	39.35	30.12	38.17
Diluted EPS Before Extra, 5 Yr. CAGR %	-40.88	-45.68	-56.7	-35.74	-3.48
Accounts Receivable, 5 Yr. CAGR %	55.1	2.28	-46.11	-20.33	-11.83
Net Property, Plant and Equip., 5 Yr. CAGR %	73.1	66.06	22.69	-5.46	2.63
Total Assets, 5 Yr. CAGR %	38.22	41.63	26.84	30.93	20.84
Tangible Book Value, 5 Yr. CAGR %	137.54	162.02	203.3	41.3	30.38
Common Equity, 5 Yr. CAGR %	39.26	43.96	36.3	32.07	22.1
Cash From Operations, 5 Yr. CAGR %	46.58	65.23	25.36	51.85	52.75
Capital Expenditures, 5 Yr. CAGR %	18.77	149.65	2.3	-45.48	-
Levered Free Cash Flow, 5 Yr. CAGR %	76.94	92.78	13.03	103.85	41.09
Unlevered Free Cash Flow, 5 Yr. CAGR %	77.77	93.26	13.03	103.98	41.09